Cargando…
The paradoxical effect of IL-6 and implications for the use of Tocilizumab in Covid-19 patients
In the context of the current SARS-CoV-2 pandemic, patients affected by chronic obstructive pulmonary disease (COPD) should be more vulnerable to Covid-19, whereas they seem to be protected against severe Covid-19. That paradox has important practical implications for the use of the drug Tocilizumab...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500330/ https://www.ncbi.nlm.nih.gov/pubmed/33245278 http://dx.doi.org/10.1016/j.mehy.2020.110284 |